For adeno-associated virus (AAV)-based gene therapies, the need for reliable and scalable production is paramount. Traditional production methods face issues with scalability and consistency, ...

Viralgen and two labs based in the Broad Institute of MIT (Massachusetts Institute of Technology) and Harvard Univers ...

ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for ...

Andelyn currently offers both adherent and suspension mode manufacturing of research grade AAV vectors up to 200 L in scale, to support preclinical studies including viral vector process and ...